KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EBIT (2016 - 2019)

National Health Investors (NHI) has disclosed EBIT for 11 consecutive years, with $42.8 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, EBIT rose 4.33% year-over-year to $42.8 million, compared with a TTM value of $159.4 million through Sep 2019, up 1.47%, and an annual FY2019 reading of $217.6 million, up 6.59% over the prior year.
  • EBIT was $42.8 million for Q3 2019 at National Health Investors, up from $40.0 million in the prior quarter.
  • Across five years, EBIT topped out at $46.4 million in Q4 2016 and bottomed at $18.6 million in Q2 2016.
  • Average EBIT over 5 years is $37.8 million, with a median of $39.1 million recorded in 2017.
  • The sharpest move saw EBIT crashed 54.63% in 2016, then skyrocketed 105.61% in 2017.
  • Year by year, EBIT stood at $42.1 million in 2015, then increased by 10.22% to $46.4 million in 2016, then dropped by 15.71% to $39.1 million in 2017, then increased by 4.83% to $41.0 million in 2018, then increased by 4.33% to $42.8 million in 2019.
  • Business Quant data shows EBIT for NHI at $42.8 million in Q3 2019, $40.0 million in Q2 2019, and $35.7 million in Q1 2019.